167 related articles for article (PubMed ID: 36617511)
1. Pyrazole scaffold-based derivatives: A glimpse of α-glucosidase inhibitory activity, SAR, and route of synthesis.
Firdaus JU; Siddiqui N; Alam O; Manaithiya A; Chandra K
Arch Pharm (Weinheim); 2023 May; 356(5):e2200421. PubMed ID: 36617511
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Substituted Pyrazole-Fused Oleanolic Acid Derivatives as Novel Selective α-Glucosidase Inhibitors.
Gao M; Ma H; Liu X; Zhang Y; Tang L; Zheng Z; Zhang X; Jiang C; Lin L; Sun H
Chem Biodivers; 2023 Feb; 20(2):e202201178. PubMed ID: 36573561
[TBL] [Abstract][Full Text] [Related]
4. In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Chaudhry F; Naureen S; Huma R; Shaukat A; Al-Rashida M; Asif N; Ashraf M; Munawar MA; Khan MA
Bioorg Chem; 2017 Apr; 71():102-109. PubMed ID: 28160945
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.
Azimi F; Azizian H; Najafi M; Hassanzadeh F; Sadeghi-Aliabadi H; Ghasemi JB; Ali Faramarzi M; Mojtabavi S; Larijani B; Saghaei L; Mahdavi M
Bioorg Chem; 2021 Sep; 114():105127. PubMed ID: 34246971
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.
Kashtoh H; Muhammad MT; Khan JJ; Rasheed S; Khan A; Perveen S; Javaid K; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Bioorg Chem; 2016 Apr; 65():61-72. PubMed ID: 26874344
[TBL] [Abstract][Full Text] [Related]
9. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
Dhameja M; Gupta P
Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
11. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
[TBL] [Abstract][Full Text] [Related]
12. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
13. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S
Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965
[TBL] [Abstract][Full Text] [Related]
14. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
[TBL] [Abstract][Full Text] [Related]
15. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
Leong SW; Abas F; Lam KW; Yusoff K
Bioorg Med Chem Lett; 2018 Feb; 28(3):302-309. PubMed ID: 29292226
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study.
Rahim F; Zaman K; Taha M; Ullah H; Ghufran M; Wadood A; Rehman W; Uddin N; Shah SAA; Sajid M; Nawaz F; Khan KM
Bioorg Chem; 2020 Jan; 94():103394. PubMed ID: 31699396
[TBL] [Abstract][Full Text] [Related]
20. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
